These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 38695786)
21. Low serotonin1B receptor binding potential in the anterior cingulate cortex in drug-free patients with recurrent major depressive disorder. Tiger M; Farde L; Rück C; Varrone A; Forsberg A; Lindefors N; Halldin C; Lundberg J Psychiatry Res Neuroimaging; 2016 Jul; 253():36-42. PubMed ID: 27269199 [TBL] [Abstract][Full Text] [Related]
22. [Escitalopram is more effective than citalopram for the treatment of severe major depressive disorder]. Azorin JM; Llorca PM; Despiegel N; Verpillat P Encephale; 2004; 30(2):158-66. PubMed ID: 15107719 [TBL] [Abstract][Full Text] [Related]
23. Serotonin 1A receptor density measured by F18-Mefway PET/CT in mesiotemporal cortex and raphe does not discriminate therapeutic response in patients with major depressive episode. Barth M; Dunzinger A; Wimmer I; Winkler J; Rittmannsberger H; Nader M; Pichler R Q J Nucl Med Mol Imaging; 2020 Jun; 64(2):203-210. PubMed ID: 29916219 [TBL] [Abstract][Full Text] [Related]
24. A positron emission tomography study of the serotonin1B receptor effect of electroconvulsive therapy for severe major depressive episodes. Tiger M; Gärde M; Tateno A; Matheson GJ; Sakayori T; Nogami T; Moriya H; Varnäs K; Arakawa R; Okubo Y J Affect Disord; 2021 Nov; 294():645-651. PubMed ID: 34332365 [TBL] [Abstract][Full Text] [Related]
26. Influence of escitalopram treatment on 5-HT 1A receptor binding in limbic regions in patients with anxiety disorders. Spindelegger C; Lanzenberger R; Wadsak W; Mien LK; Stein P; Mitterhauser M; Moser U; Holik A; Pezawas L; Kletter K; Kasper S Mol Psychiatry; 2009 Nov; 14(11):1040-50. PubMed ID: 18362913 [TBL] [Abstract][Full Text] [Related]
27. [Escitalopram: a selective inhibitor and allosteric modulator of the serotonin transporter]. Mnie-Filali O; El Mansari M; Scarna H; Zimmer L; Sánchez C; Haddjeri N Encephale; 2007 Dec; 33(6):965-72. PubMed ID: 18789789 [TBL] [Abstract][Full Text] [Related]
28. The effect of selective serotonin reuptake inhibitors in healthy first-degree relatives of patients with major depressive disorder - an experimental medicine blinded controlled trial. Knorr UB Dan Med J; 2012 Apr; 59(4):B4426. PubMed ID: 22459724 [TBL] [Abstract][Full Text] [Related]
29. Escitalopram: a review of its use in the management of major depressive disorder in adults. Garnock-Jones KP; McCormack PL CNS Drugs; 2010 Sep; 24(9):769-96. PubMed ID: 20806989 [TBL] [Abstract][Full Text] [Related]
30. Clinical implications of directly switching antidepressants in well-treated depressed patients with treatment-emergent sexual dysfunction: a comparison between vortioxetine and escitalopram. Jacobsen PL; Nomikos GG; Zhong W; Cutler AJ; Affinito J; Clayton A CNS Spectr; 2020 Feb; 25(1):50-63. PubMed ID: 31010445 [TBL] [Abstract][Full Text] [Related]
31. Brain monoamine oxidase A binding in major depressive disorder: relationship to selective serotonin reuptake inhibitor treatment, recovery, and recurrence. Meyer JH; Wilson AA; Sagrati S; Miler L; Rusjan P; Bloomfield PM; Clark M; Sacher J; Voineskos AN; Houle S Arch Gen Psychiatry; 2009 Dec; 66(12):1304-12. PubMed ID: 19996035 [TBL] [Abstract][Full Text] [Related]
32. Serotonin 1A Receptor Binding of [11C]CUMI-101 in Bipolar Depression Quantified Using Positron Emission Tomography: Relationship to Psychopathology and Antidepressant Response. Lan MJ; Zanderigo F; Pantazatos SP; Sublette ME; Miller J; Ogden RT; Mann JJ Int J Neuropsychopharmacol; 2022 Aug; 25(7):534-544. PubMed ID: 34996114 [TBL] [Abstract][Full Text] [Related]
33. Serotonin transporter occupancy with TCAs and SSRIs: a PET study in patients with major depressive disorder. Lundberg J; Tiger M; Landén M; Halldin C; Farde L Int J Neuropsychopharmacol; 2012 Sep; 15(8):1167-72. PubMed ID: 22243688 [TBL] [Abstract][Full Text] [Related]
34. Escitalopram enhances the association of serotonin-1A autoreceptors to heteroreceptors in anxiety disorders. Hahn A; Lanzenberger R; Wadsak W; Spindelegger C; Moser U; Mien LK; Mitterhauser M; Kasper S J Neurosci; 2010 Oct; 30(43):14482-9. PubMed ID: 20980606 [TBL] [Abstract][Full Text] [Related]
35. Tryptophan depletion and serotonin loss in selective serotonin reuptake inhibitor-treated depression: an [(18)F] MPPF positron emission tomography study. Praschak-Rieder N; Hussey D; Wilson AA; Carella A; Lee M; Dunn E; Willeit M; Bagby RM; Houle S; Meyer JH Biol Psychiatry; 2004 Oct; 56(8):587-91. PubMed ID: 15476688 [TBL] [Abstract][Full Text] [Related]
36. [Mechanisms of action of antidepressants: new data from Escitalopram]. Fabre V; Hamon M Encephale; 2003; 29(3 Pt 1):259-65. PubMed ID: 12876551 [TBL] [Abstract][Full Text] [Related]
37. Decreased Pretreatment Amygdalae Serotonin Transporter Binding in Unipolar Depression Remitters: A Prospective PET Study. Ananth MR; DeLorenzo C; Yang J; Mann JJ; Parsey RV J Nucl Med; 2018 Apr; 59(4):665-670. PubMed ID: 28935838 [TBL] [Abstract][Full Text] [Related]